Skip to content

PG

NYSE
Favorable· 63

The Procter & Gamble Company

Consumer Defensive
Household & Personal Products

$148.00

1.2%

Updated Sep 2, 2:21 PM ET

Report Card

PG at a glance — five pillars scored 0–100 from real filed financials.

Value
0
Growth
0
Profitability
0
Health
0
Dividends
0

Overall: Favorable · 63/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.

Price — Past Year

▼ Down 4.8% over the last 12 months

Price 50-day average 200-day averageDCF fair value ±15%Source: Yahoo Finance · refreshed daily
Key Metrics

Market Cap

$352.57B

P/E

20.69x

Forward P/E (est.)

19.05x

ROE

31.2%

Revenue Growth

3.3%

EPS Growth

8.6%

Profit Margin

19.2%

FCF Yield

4.7%

Debt / Equity

0.66x

ROIC

67.0%

Interest Coverage

26.12x

Current Ratio

0.68x

Dividend Yield

2.9%

Implied Growth (rev. DCF)

4.5%

Rating Score

63/100

Business Overview
Research

Procter & Gamble is a defensive consumer-staples anchor with pricing power across trusted brands and a multi-decade dividend-growth record. Growth is modest, but the earnings and cash flows are exceptionally stable through cycles.

Economic Moat

Evidence of durable competitive advantage in the filed financials (10 years of history).

Wide moat signalsMoat evidence score: 78/100

The filed history looks like a business competitors struggle to attack: high and steady margins, revenue that grows through cycles, and strong returns on capital.

Operating margin level56/100

23.0% average over the last 3 years

Operating margin stability45/100

±4.4 pts around 20.8% across 10 years

Revenue durability100/100

grew in 9 of the last 9 year-over-year periods

Free-cash-flow consistency100/100

positive in 10 of 10 years

Return on invested capital100/100

67.0% latest fiscal year

A moat can't be proven by numbers alone — this scores the evidence a durable advantage leaves behind (pricing power, consistency, returns on capital), computed the same way for every stock. Pair it with the business overview before concluding anything.

Trade Setup & Technical Analysis

Institutional-style technical read — sample, educational only

Neutral
Confidence score63/100

Sideways — price ($148.00) sits between its 50-day ($146.14) and 200-day ($148.55) averages.

Setup type

Range / mean-reversion

Holding time

1–6 weeks

Risk level

Low

Risk / reward

1 : 1.0

Trade levels

Entry zone

$143.56 – $148.00

Stop loss

$138.41

Target 1

$153.35

Target 2

$158.36

Target 3

$162.80

Position sizing: Standard size; risk ≤ 1.5% of capital.

Technical analysis

RSI(14) is firm (56); the MACD histogram is negative (downward momentum). Sideways — price ($148.00) sits between its 50-day ($146.14) and 200-day ($148.55) averages. ATR(14) is $2.96 (~2.0% of price), which sets the stop distance. Recent support sits near $139.89 and resistance near $153.35; the 52-week range is $137.62–$167.25.

Fundamental analysis

Revenue is stable at 3.3%, net margin near 19.2%, ROE roughly 31.2%; shares trade at 21x earnings. Quality score: 63/100.

Options flow

Live options-flow data needs a paid feed, so it isn't shown. For realized volatility, ATR of $2.96 (~2.0%/day) is the range to size stops and any option strikes around.

Volume analysis

The latest session traded 1.0× the 20-day average volume — roughly in line with normal activity.

Catalysts

The next quarterly earnings report is the main near-term catalyst. Technically, watch for a break and hold above $153.35 or a loss of $139.89.

Bullish scenario

Brand strength and pricing power protect margins through inflation.

Bearish scenario

Low-single-digit organic growth limits upside.

Invalidation

A daily close below $138.41 invalidates this setup read.

Probability-based scenario using sample data — not a recommendation or a guarantee of profit. Prioritize capital preservation, use stops, and size positions for risk. Past performance does not predict future results.

Technical Analysis (Educational)
Research

Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what PG's chart says today, with each tool explained.

Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. PG trades near $148.00, around its 50-day average ($146.14) and 200-day average ($148.55). Price tangled in its moving averages means there is no clear trend — the stock is ranging.

Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 56 it is in neutral territory — neither stretched nor washed out.

MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently negative — short-term momentum is fading.

Volatility — ATR. Average True Range is the typical daily move. PG's is $2.96 (~2.0% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.

Support & resistance. Over the last month PG found buyers near $139.89 (support) and sellers near $153.35 (resistance); its 52-week range is $137.62–$167.25. A decisive break beyond either edge often marks the next move.

Volume. The latest session traded 1.0× the 20-day average — about normal. Rising volume on up-days suggests real buying; on down-days, real selling.

Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.

Revenue Growth
Research

4Y CAGR

2.1%

4/4 checks passedRevenue growingRevenue growth beats sector midpointEPS growingEPS growing faster than revenue

Revenue grew from $65.06B in 2017 to $87.03B in 2026, a 3.3% CAGR. The most recent year grew about 3.3% year over year, a moderate pace consistent with a mature business.

Profitability
Research
4/4 checks passedProfitableNet margin above sector midpointROE above 12%ROIC above 10%

Gross Margin

Operating Margin

22.7%

Net Margin

18.4%

ROE

31.2%

Gross margin runs near 50.9% with operating margin around 23.6% and net margin near 19.2%. Return on equity of roughly 31.2% indicates strong capital efficiency, and the margin profile has trended steady over the period shown.

Debt Analysis
Research
3/4 checks passedDebt under 1× equityDebt under 2× equityInterest covered 3×+Short-term bills covered

Total Debt

$23.13B

Net Debt

$13.82B

Net Debt / EBITDA

0.7x

Debt / Equity

0.66x

Interest-bearing debt is about 8.0% of market capitalization and the debt-to-equity ratio is roughly 0.66x. Leverage is low, leaving the balance sheet well within comfortable limits.

Cash Flow Analysis
Research
3/3 checks passedPositive free cash flowFCF yield above 2%Market expects achievable growth (<8%)

Operating CF

$19.56B

Free Cash Flow

$15.15B

FCF Margin

17.4%

Operating cash flow comfortably exceeds reported net income, and free cash flow yield is around 4.7%. Cash generation is robust and supports buybacks, dividends, and reinvestment.

Dividend Safety

Can the payout survive a bad year? Scored from filed cash flow, earnings coverage, and the raise/cut record.

SafeSafety score: 75/100

The payout is comfortably covered by cash the business actually generates, with a raise habit behind it.

Dividend yield

2.9%

Per share (latest FY)

$4.26

Total paid (latest FY)

$10.23B

History on record

10 years

Free-cash-flow coverage54/100

dividend uses 68% of free cash flow

Earnings payout ratio57/100

64% of net income paid out

Raise streak100/100

total dividends increased 9 years in a row

Cut history100/100

no cuts in the last 10 years on record

Coverage uses the latest fiscal year as filed with the SEC; the streak counts total dollars paid (per-share figures can carry split artifacts). Educational information, not income advice.

Valuation Analysis
Research
3/4 checks passedPositive earnings (P/E meaningful)P/E below sector's upper bandForward P/E below trailing (earnings growing)Trading below DCF fair value

P/E

20.69x

P/S

4.2x

P/B

6.96x

EV / EBITDA

19x

Shares trade at roughly 21x trailing earnings (24x forward), 4.2x sales, and 19x EV/EBITDA. That is a reasonable-to-cheap multiple relative to the broader market. Our internal rating is Favorable.

DCF Fair Value (Educational)

A two-stage discounted cash flow on real SEC-filed free cash flow — the intrinsic-value anchor professional analysts triangulate from.

DCF fair value / share

$107.72

Current price

$148.00

-27% · Above fair-value estimate

Starting FCF (latest 10-K)

$15.15B

Growth, years 1–5

3.3%

Fade to terminal, years 6–10

2.5%

Discount rate

9.0%

PV of 10-yr free cash flow$113.72B
PV of terminal value$136.66B
Estimated equity value$250.38B
Shares outstanding2.32B

Cash flows grow at the stage-1 rate (trailing revenue growth, capped at 20%) for five years, fade to 2.5% by year 10, and continue at that rate forever (Gordon terminal value), all discounted at 9.0%. Small changes in assumptions move the result a lot — treat this as one reference point, not a target price. Educational only, not investment advice.

Metrics vs. Sector Range

Where PG sits versus its Consumer Staples sector peers in the S&P 500.

TTM P/E
20.7xFair
Forward P/E
19.0xFair
P/S ratio
4.2xExpensive
Revenue growth
3.3%Average
EPS growth
8.6%Average
Gross margin
Net margin
19.2%Strong
ROE
31.2%Strong

Bands show the middle half (25th–75th percentile) of the 48 Consumer Staples companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.

Sector Peer Comparison

How PG stacks up against its Consumer Staples peers — valuation, profitability, and growth versus the sector median.

In the Consumer Staples sector (74 S&P 500 companies), PG ranks #6 of 74 by our overall rating. It trades at roughly in line versus the sector on earnings (20.7x P/E vs. 22.1x median) with a higher return on equity (31.2% vs. 18.1%) and slower revenue growth (3.3% vs. 3.4%).

P/E vs sector

20.7x

median 22.1x

ROE vs sector

31.2%

median 18.1%

Growth vs sector

3.3%

median 3.4%

Sector rank

#6

of 74 by rating

CompanyP/ERev Gr.Rating
PGThis stock20.7x3.3%Favorable· 63
KO28.1x5.1%Favorable· 64
COST47x9.2%Neutral· 47
PM26.2x8.1%Favorable· 62
PEP22.1x4.3%Neutral· 46
BUD22.2x3.6%Neutral· 50
SONY5.2%Weak· 28
WMT37.3x5.9%Neutral· 56
Consumer Staples median22.1x3.4%38/100

Valuation vs. quality map

sector medianKOCOSTPMPEPBUDWMTPGP/E — cheaper ←→ pricierROE — more profitable ↑

The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.

Compare side by side

Peers are the closest Consumer Staples companies by sub-industry and size. Sector median is across all 74 S&P 500 names in the sector. Educational, not a recommendation.

5-Year Projection Model

Project revenue → earnings → price. Edit the assumptions to build your own case.

2030 price target (Base Case)

$0.00 $0.00

vs. $148.00 today · expected CAGR -8%2%

Metric20262027202820292030
Revenue$89.64B$92.33B$95.10B$97.96B$100.89B
Net income$16.14B$16.62B$17.12B$17.63B$18.16B
EPS$6.77$6.98$7.19$7.40$7.62
Share price (low)$88.05$90.69$93.42$96.22$99.10
Share price (high)$142.24$146.51$150.90$155.43$160.09
CAGR (low–high)-41% / -4%-22% / -1%-14% / 1%-10% / 1%-8% / 2%

Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.

Bull Case
  • Brand strength and pricing power protect margins through inflation.
  • Dividend King with a long record of returns to shareholders.
  • Defensive demand resilient in downturns.
Bear Case
  • Low-single-digit organic growth limits upside.
  • Premium valuation for a slow grower.
  • Private-label and FX headwinds.
Key Risks
Research
  • Currency translation drag.
  • Input-cost inflation.
  • Trade-down to private label.
Final Investment Thesis
Research

P&G is a low-volatility staples compounder for conservative, income-focused investors. Expectations should center on dividends and stability rather than growth.

Analyst Ratings

What 37 Wall Street analysts covering PG recommend (September 2026). Consensus is a useful sanity check — not a substitute for your own homework.

Buy
consensus · score 3.6 / 5 across 37 analysts
Strong Buy 6Buy 13Hold 17Sell 1Strong Sell 0

Analysts have turned more cautious over the last three months (-10 pts of buy ratings).

Latest SEC Filings

PG's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen.

In the Idea Lab

PG — frequently asked questions

Is PG a good stock to buy?

We don't give buy or sell advice. Our model rates The Procter & Gamble Company Favorable (63/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.

What is PG's rating on The Stocks School?

The Procter & Gamble Company currently scores 63/100 (Favorable) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.

How our ratings work
Where does PG's data come from?

Live price data plus real fundamentals and 5-year financials pulled directly from The Procter & Gamble Company's SEC filings — refreshed automatically, not hand-entered.

How is the 5-year projection for PG calculated?

It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.

Is this PG analysis financial advice?

No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell PG. Always do your own research and consider a licensed professional.

Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.

Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.